<DOC>
	<DOCNO>NCT00688831</DOCNO>
	<brief_summary>The purpose study safety AZD1305 , AZD1305 tolerate medication metabolise body ( take body , distribute around body disappear body</brief_summary>
	<brief_title>Single Ascending Dose Study ( SAD ) iv Formulation</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy volunteer BIM 1930 kg/m2 Potassium outside normal reference value ECG finding outside normal range</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>AZD1305</keyword>
	<keyword>SAD</keyword>
	<keyword>safety</keyword>
	<keyword>pharmcokinetics</keyword>
	<keyword>Safety tolerability</keyword>
</DOC>